{
    "title": "Novartis prices lung cancer drug at $17,950 for 28-day supply",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-8294193/U-S-FDA-approves-Novartis-drug-hard-treat-type-lung-cancer.html",
    "date": "2020-05-06",
    "keywords": [
        "tabrecta",
        "lung",
        "cancer",
        "novartis",
        "treatment",
        "approval",
        "drug",
        "company",
        "manojna",
        "maddipatla",
        "wednesday",
        "form",
        "cell",
        "type",
        "metex14",
        "pfizer",
        "year",
        "fda",
        "mishra",
        "acquisition",
        "cost",
        "supply",
        "food",
        "administration",
        "schedule",
        "met",
        "exon14",
        "body",
        "regardless",
        "nonsmall",
        "prognosis",
        "arsenal",
        "inc",
        "race",
        "fasttrack",
        "development",
        "nsclc",
        "mid2020s",
        "piper",
        "sandler",
        "analyst",
        "tyler",
        "van",
        "buren",
        "client",
        "note",
        "blockbuster",
        "contrast",
        "country",
        "corp",
        "priority",
        "review",
        "milestone",
        "incyte",
        "medicine",
        "incs",
        "foundationone",
        "cdx",
        "companion",
        "test",
        "reporting",
        "bengaluru",
        "editing",
        "dasgupta",
        "kuber"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}